To provide a forum for key cancer stakeholders to join with business, finance, and legal thought leaders to explore the future course for oncology, ASCO is co-hosting the seventh annual Cancer Center Business Summit on October 24 and 25 in Chicago, Illinois. Designed as a resource for the business side of oncology, the event, themed “Transforming Oncology Through Innovation,” features presentations and panels that address an array of issues affecting practice, including value-based payment models and federal payment reform, oncologist-hospital relationships, emerging business models, and market strategies in cancer care.
According to Sandra M. Swain, MD, FACP, ASCO Immediate Past President and Medical Director of Washington Cancer Institute MedStar Washington Hospital Center, “Today’s market and government reform dynamics require innovative solutions to drive care quality improvements while reducing costs. To help meet those demands, the Cancer Center Business Summit allows industry leaders to collaborate in developing sustainable business models for high-quality cancer care delivery.”
2013 Program Highlights
ASCO CEO Allen Lichter, MD, will deliver the opening remarks, painting a picture of the future of oncology. The next session will address health plan payers’ market dynamics, setting the stage for four case studies of paired provider-payer initiatives in care process and payment redesign. The case studies will highlight project results, lessons learned, and plans for the future. Another theme featured proximately in the program is the evolution of data analytics in oncology, aiming to provide attendees with the information and resources needed to extract the full value from clinical and financial data in anticipation of likely payment bundling in the near future.
Other sessions will address topics such as academic medical center and community oncology alignment, mobile technology innovations in health care, the development of oncology-specific accountable care organizations and oncology medical homes, oncology standards and measures in value-based payment systems, options for oncology practice integration that preserve private practice, alternative oncology payment arrangements, issues in valuing oncology transactions, emerging business models in genomics and precision medicine, and strategies and structures for radiation therapy programmatic success.
Target Audience
According to Ronald Barkley, MS, JD, President of Cancer Center Business Development Group and co-founder of the Cancer Center Business Summit, “Stakeholders in cancer care delivery who are seeking to be part of the transformation of oncology from the current payment and care delivery systems to the target value-based systems will benefit from attending the Summit.” He noted that the event will identify resources to help navigate the rapidly changing business landscape and provide a window into peers’ efforts to prepare for and transform the future of cancer care delivery.
For More Information
For the latest information on the 2013 Cancer Center Business Summit, visit www.cancerbusinesssummit.com to register, view the agenda, and learn more about the event hosts, advisory board, speakers, and sponsors. ■
© 2013. American Society of Clinical Oncology. All rights reserved.
